Thoracic Surgery
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GetingeHigh-flow nasal cannula
Merck & Co.intraoperative neuromuscular blockade
GrifolsAlbumin
Clinical Trials (3)
Total enrollment: 158 patients across 3 trials
High Flow Nasal Cannula in Thoracic Surgery: a Physiologic Study
Start: Feb 2020Est. completion: Dec 202040 patients
N/AUnknown
Intraoperative Neuromuscular Blockade and Postoperative Atelectasis
Start: Oct 2018Est. completion: May 2021118 patients
N/ACompleted
Albumin Administration and Outcomes in Cardiac Surgery
Start: Jan 2012Est. completion: Mar 2013
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space